Clarivate

NOVEMBER 17, 2021

In this episode of Conversations in Healthcare , Carolyn Hynes from AstraZeneca discusses the importance of regulatory intelligence. Subscribe to Conversations in Healthcare . We’ve also released a complimentary report on this podcast topic, Showing the value of regulatory intelligence in pharma.

Pharma 52

Pharma Healthcare Healthcare Specialization 52

Clarivate

MARCH 14, 2024

With the introduction of a new CMC Intelligence entitlement to address post-approval changes, Clarivate now covers a broader range of the lifecycle of pharmaceutical products. Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt. Impending change affords an opportunity for innovation.

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

pharmaphorum

SEPTEMBER 28, 2022

A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence generation to support the design of an asset. In recent years, the biopharma market has become progressively complex.

Biopharma 52

Biopharma Side effects Consulting Pharmaceutical products 52